Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Dansk
English
Search content at The Capital Region of Denmark's Research Portal
Home
Hospitals/Departments
Researchers
Research output
Activities
Prizes
Aclidinium bromid forbedrer lungefunktionen og reducerer dyspnø hos patienter med KOL
Translated title of the contribution
:
Aclidinium bromide improves the lung function and reduces dyspnoea in patients with COPD.
Charlotte Suppli Ulrik
Respiratory Unit
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Aclidinium bromide improves the lung function and reduces dyspnoea in patients with COPD.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Dyspnea
100%
Lung Function
100%
Aclidinium Bromide
100%
Aclidinium
66%
COPD Treatment
66%
Health Status
33%
Forced Expiratory Volume in 1 Second (FEV1)
33%
Nighttime
33%
Rescue Medication
33%
Twice-daily Dosing
33%
COPD Management
33%
Exacerbation Rate
33%
Exercise Tolerance
33%
Long-acting Bronchodilators
33%
Future Management
33%
Anticholinergic Bronchodilators
33%
Long-acting Anticholinergic
33%
Clinically Meaningful Improvement
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Dyspnea
100%
Aclidinium Bromide
100%
Bronchodilating Agent
40%
Health Status
20%
Cholinergic Receptor Blocking Agent
20%